Aerie Pharmaceuticals, Inc. Names Marvin J. Garrett As Vice President, Regulatory Affairs And Quality Assurance

Published: Feb 25, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that Marvin J. Garrett has been named Vice President, Regulatory Affairs and Quality Assurance of the Company.

Help employers find you! Check out all the jobs and post your resume.

Back to news